Skip to main content
Kent Academic Repository

A retrospective study of intramuscular clozapine prescription for treatment initiation and maintenance in treatment-resistant psychosis

Casetta, Cecilia, Oloyede, Ebenezer, Whiskey, Eromona, Taylor, David Michael, Gaughran, Fiona, Shergill, Sukhi S., Onwumere, Juliana, Segev, Aviv, Dzahini, Olubanke, Legge, Sophie E, and others. (2020) A retrospective study of intramuscular clozapine prescription for treatment initiation and maintenance in treatment-resistant psychosis. British Journal of Psychiatry, 217 (3). pp. 506-513. ISSN 0007-1250. (doi:10.1192/bjp.2020.115) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:96379)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. (Contact us about this Publication)
Official URL:
https://doi.org/10.1192/bjp.2020.115

Abstract

BACKGROUND: Clozapine is uniquely effective in treatment-resistant psychosis but remains underutilised, partly owing to psychotic symptoms leading to non-adherence to oral medication. An intramuscular formulation is available in the UK but outcomes remain unexplored.AIMS: This was a retrospective clinical effectiveness study of intramuscular clozapine prescription for treatment initiation and maintenance in treatment-resistant psychosis over a 3-year period.METHOD: Successful initiation of oral clozapine after intramuscular prescription was the primary outcome. Secondary outcomes included all-cause clozapine discontinuation 2 years following initiation, and 1 year after discharge. Discontinuation rates were compared with a cohort prescribed only oral clozapine. Propensity scores were used to address confounding by indication.RESULTS: Among 39 patients prescribed intramuscular clozapine, 19 received at least one injection, whereas 20 accepted oral clozapine when given an enforced choice between the two. Thirty-six (92) patients successfully initiated oral clozapine after intramuscular prescription; three never transitioned to oral. Eight discontinued oral clozapine during the 2-year follow-up, compared with 83 out of 162 in the comparator group (discontinuation rates of 24 and 50, respectively). Discontinuation rates at 1-year post-discharge were 21, compared with 44 in the comparison group. Intramuscular clozapine prescription was associated with a non-significantly lower hazard of discontinuation 2 years after initiation (hazard ratio 0.39, 95 CI 0.14-1.06) and 1 year after discharge (hazard ratio 0.37, 95 CI 0.11-1.24). The only reported adverse event specific to the intramuscular formulation was injection site pain and swelling.CONCLUSIONS: Intramuscular clozapine prescription allowed transition to oral maintenance in an initially non-adherent cohort. Discontinuation rates were similar to patients only prescribed oral clozapine and comparable to existing literature.

Item Type: Article
DOI/Identification number: 10.1192/bjp.2020.115
Uncontrolled keywords: Intramuscular clozapine, clozapine, clozapine discontinuation, schizophrenia, treatment-resistant schizophrenia
Subjects: R Medicine
Divisions: Divisions > Division of Natural Sciences > Kent and Medway Medical School
Funders: National Institute for Health Research (https://ror.org/0187kwz08)
NIHR Imperial Biomedical Research Centre (https://ror.org/01kmhx639)
South London and Maudsley NHS Foundation Trust (https://ror.org/015803449)
King's College London (https://ror.org/0220mzb33)
Depositing User: Rachael Heller
Date Deposited: 28 Sep 2022 15:20 UTC
Last Modified: 05 Nov 2024 13:01 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/96379 (The current URI for this page, for reference purposes)

University of Kent Author Information

  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.